Related Experiment Video
Updated: Mar 9, 2026
RhoC GTPase Activation Assay
Published on: August 22, 2010
Rho GTPases: Anti- or pro-neoplastic targets?
I Zandvakili1,2,3, Y Lin1, J C Morris4
1Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Abstract:
Rho GTPases are critical signal transducers of multiple pathways. They have been proposed to be useful anti-neoplastic targets for over two decades, especially in Ras-driven cancers. Until recently, however, few in vivo studies had been carried out to test this premise. Several recent mouse model studies have verified that Rac1, RhoA, and some of their effector proteins such as PAK and ROCK, are likely anti-cancer targets for treating K-Ras-driven tumours. Other seemingly contradictory studies have suggested that at least in certain instances inhibition of individual Rho GTPases may paradoxically result in pro-neoplastic effects. Significantly, both RhoA GTPase gain- and loss-of-function mutations have been discovered in primary leukemia/lymphoma and gastric cancer by human cancer genome sequencing efforts, suggesting both pro- and anti-neoplastic roles. In this review we summarize and integrate these unexpected findings and discuss the mechanistic implications in the design and application of Rho GTPase targeting strategies in future cancer therapies.
Insights
Rho GTPases show promise as anti-cancer targets, particularly in Ras-driven cancers. However, recent studies reveal complex roles, with some inhibiting and others promoting tumor growth, necessitating careful therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Signal Transduction
Background:
- Rho GTPases are key regulators of cellular signaling pathways.
- Their role as anti-cancer targets, especially in Ras-driven cancers, has been explored for over 20 years.
- Recent in vivo studies are beginning to validate their therapeutic potential.
Purpose of the Study:
- To review and integrate recent findings on Rho GTPase roles in cancer.
- To discuss the implications of these findings for cancer therapy design.
- To explore the dual pro- and anti-neoplastic roles of Rho GTPases.
Main Methods:
- Review of recent in vivo mouse model studies.
- Analysis of human cancer genome sequencing data.
- Integration of findings on Rho GTPase effector proteins (PAK, ROCK).
Main Results:
- Mouse models confirm Rac1 and RhoA as potential anti-cancer targets for K-Ras-driven tumors.
- Some studies indicate paradoxical pro-neoplastic effects upon Rho GTPase inhibition.
- Gain- and loss-of-function RhoA mutations in leukemia/lymphoma and gastric cancer suggest complex roles.
Conclusions:
- Rho GTPase targeting strategies require careful consideration due to their complex, context-dependent roles in cancer.
- Further mechanistic studies are needed to optimize Rho GTPase-based cancer therapies.
- Understanding both pro- and anti-neoplastic functions is crucial for effective drug development.
Related Concept Videos
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
02:14GTPases and their Regulation
Large G-proteins,...
02:14GTPases and their Regulation
02:38The Ras Gene
Ras is a...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:22Activation and Inactivation of G Proteins